FRANKLIN, Massachusetts, Dec. 7, 2016 /PRNewswire/ –Arthrosurface®, an orthopedic medical technology company focused on the orthopedic upper and lower extremities markets, has named Joe Darling as the Company’s Executive Chairman. Mr. Darling will join the company in this newly created position shaping the future strategic direction with respect to, and overseeing and directing, the company’s commercial activities and business operations. The company has added Mr. Darling to their Board of Directors.
Mr. Darling’s business career spans both the pharmaceutical and medical device markets including senior management positions with Abbott Laboratories, Wyeth Pharmaceuticals, and executive level positions with Baxter International as Vice President of Marketing and Health Systems, Senior Vice President and General Manager of Smith and Nephews Sports Medicine and Biologics business, Global President of Linvatec Corporation, and Executive Vice President, Corporate Commercial Operations with CONMED Corporation, and most recently as Chief Operating Officer with Interventional Spine, Inc.
Joe’s proven leadership skills have spanned many functional areas in general management including sales, marketing, R&D, operations, regulatory and quality, finance and human resources. “Mr. Darling is well known within the orthopedic market and brings a vast knowledge of the industry to Arthrosurface. We are excited to have Joe on board,” said Dana Callow, Managing General Partner of Boston Millennia Partners. “Joe’s depth of experience and leadership skills will provide the Arthrosurface team with the strategic direction and experience necessary to accelerate the global profitable growth of the company.”
“Joe has deep experience in the global development and launch of innovative orthopedic products and we are excited to have him join the Arthrosurface team,” said Steve Ek, CEO and Founder. “We look forward to utilizing Joe’s deep understanding of the orthopedic markets along with his extensive relationships across the industry.”
“I am pleased to join Arthrosurface and look forward to working with the Arthrosurface team as we reshape the strategic direction of the company” Mr. Darling said.
Arthrosurface, Inc. is a global orthopedic medical technology business providing a broad portfolio of essential products and instrumentation used to treat upper and lower extremity orthopedic conditions caused by trauma, injury and arthritic disease. The product offerings include devices, instruments and biologics designed to preserve and restore the joints so patients can maintain an active lifestyle. The Company offers a variety of unique systems that provide less invasive technologies for surgeons that can be used to treat a wide range of joint conditions. Founded in 2002, Arthrosurface markets and distributes its products in the US and around the world and has succeeded in helping patients return to activity for over 13 years.
© 2016 PR Newswire